CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
- PMID: 14973555
- DOI: 10.1038/sj.onc.1207249
CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
Abstract
The calcium-activated chloride channel gene family is clustered in the 1p31 region, which is frequently deleted in sporadic breast cancer. Recent studies have indicated the association of the second member of this gene family (CLCA2) with the development of breast cancer and metastasis. We have now shown the absence of expression of CLCA2 in several breast cancer tumours and cell lines, which confirms the results from other reports. When overexpressed in CLCA2-negative cell lines, their tumorigenicity and metastasis capability were significantly reduced, suggesting a tumour suppressor role for CLCA2 in breast cancer. The mechanisms behind the silencing of CLCA2 in breast cancer, however, have not been elucidated to date. Although we were able to identify CLCA2 mutations in breast cancers, somatic mutations are not the major cause of CLCA2 gene silencing. On the other hand, treatment of breast cancer CLCA2-negative cell lines with demethylating agents was able to restore CLCA2 expression, suggesting an epigenetic inactivation of this gene. Bisulphite-sequencing of the promoter-associated CpG island of the CLCA2 gene in breast tumours demonstrated that the absence of expression in these tumours was caused by hypermethylation of the promoter CpG island. In contrast, in breast cancer cell lines, tumours, and control cell lines that express CLCA2, a much lower level, and often absence, of methylation of the promoter were demonstrated. These findings demonstrate that CLCA2 is frequently inactivated in breast cancer by promoter region hypermethylation, which makes it an excellent candidate for the 1p31 breast cancer tumour suppressor gene.
Similar articles
-
SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.Cancer Res. 2002 Oct 15;62(20):5874-80. Cancer Res. 2002. PMID: 12384551
-
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30. Breast Cancer Res. 2008. PMID: 18826564 Free PMC article.
-
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.Oncogene. 2003 Feb 13;22(6):947-54. doi: 10.1038/sj.onc.1206191. Oncogene. 2003. PMID: 12584574
-
Gene silencing by DNA methylation in haematological malignancies.Br J Haematol. 2007 Jul;138(1):3-11. doi: 10.1111/j.1365-2141.2007.06604.x. Epub 2007 May 9. Br J Haematol. 2007. PMID: 17489980 Review.
-
Chromosome 3p and breast cancer.J Hum Genet. 2002;47(9):453-9. doi: 10.1007/s100380200064. J Hum Genet. 2002. PMID: 12202982 Review.
Cited by
-
Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis.Oncogene. 2012 Apr 26;31(17):2237-46. doi: 10.1038/onc.2011.392. Epub 2011 Sep 12. Oncogene. 2012. PMID: 21909135 Free PMC article.
-
hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation.Cancer Res. 2009 Aug 15;69(16):6624-32. doi: 10.1158/0008-5472.CAN-08-4101. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654313 Free PMC article.
-
CLCA2 suppresses the proliferation, migration and invasion of cervical cancer.Exp Ther Med. 2021 Jul;22(1):776. doi: 10.3892/etm.2021.10208. Epub 2021 May 18. Exp Ther Med. 2021. PMID: 34055075 Free PMC article.
-
TPSC: a module detection method based on topology potential and spectral clustering in weighted networks and its application in gene co-expression module discovery.BMC Bioinformatics. 2021 Oct 25;22(Suppl 4):111. doi: 10.1186/s12859-021-03964-5. BMC Bioinformatics. 2021. PMID: 34689740 Free PMC article.
-
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.Breast Cancer Res. 2011 Sep 20;13(5):R90. doi: 10.1186/bcr3015. Breast Cancer Res. 2011. PMID: 21542898 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical